Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Clinical trial NCT03233438 · COMPLETED
Trial details
- NCT number
- NCT03233438
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2018-10-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.